Onderzoeker
Katleen Vereecken
Publicaties
1 - 10 van 33
- Genome Mining Uncovers NRPS and PKS Clusters in Rothia dentocariosa with Inhibitory Activity against Neisseria Species(2023)
Auteurs: Elvis Achondou Akomoneh, Zina Gestels, Saïd Abdellati, K Vereecken, Koen Bartholomeeusen, Dorien Van den Bossche, Christopher Kenyon, Sheeba Santhini Manoharan-Basil
- Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant(2022)
Auteurs: Kevin Ariën, L Heyndrickx, J Michiels, K Vereecken, Kurt Van Lent, Sandra Coppens, B Willems, Pieter Pannus, Geert A Martens, M. Van Esbroeck, et al.
- Chikungunya virus' high genomic plasticity enables rapid adaptation to restrictive A549 cells(2022)
Auteurs: Lien De Caluwe, L Heyndrickx, Sandra Coppens, K Vereecken, Miguel E Quiñones-Mateu, Andres Merits, Kevin Ariën, Koen Bartholomeeusen
- The CD147 protein complex is involved in entry of chikungunya virus and related alphaviruses in human cells(2021)
Auteurs: Lien De Caluwe, Sandra Coppens, K Vereecken, Simon Daled, Maarten Dhaenens, Xaveer Van Ostade, Dieter Deforce, Kevin Ariën, Koen Bartholomeeusen
- A Chikungunya virus trans-replicase system reveals the importance of delayed nonstructural polyprotein processing for efficient replication complex formation in mosquito cells(2018)
Auteurs: Koen Bartholomeeusen, Age Utt, Sandra Coppens, Kai Rausalu, K Vereecken, Kevin Ariën, Andres Merits
- Resistance and cross-resistance profile of the diaryltriazine NNRTI and candidate microbicide UAMC01398(2016)
Auteurs: Kevin Ariën, Muthusamy Venkatraj, J Michiels, Jurgen Joossens, K Vereecken, Pieter Van der Veken, Jan Heeres, Hans De Winter, L Heyndrickx, Koen Augustyns, et al.
Pagina's: 1159-1168 - The N276 glycosylation site is required for HIV-1 neutralization by the CD4 binding site specific HJ16 monoclonal antibody(2013)
Auteurs: S. Balla-Jhagjhoorsingh, D. Corti, Leo Heyndrickx, Betty Willems, K Vereecken, D. Davis, G Vanham
Pagina's: e68863 - Selected HIV-1 env trimeric formulations act as potent immunogens in a rabbit vaccination model(2013)
Auteurs: Leo Heyndrickx, G. Stewart-Jones, M. Jansson, H. Schuitemaker, E. Bowles, L. Buonaguro, B. Grevstad, L. Vinner, K Vereecken, J. Parker, et al.
Pagina's: e74552 - Diaryltriazine non-nucleoside reverse transcriptase inhibitors are potent candidates for pre-exposure prophylaxis in the prevention of sexual HIV transmission(2013)
Auteurs: Kevin Ariën, M. Venkatraj, J Michiels, J. Joossens, K Vereecken, P. Van der Veken, Saïd Abdellati, Vicky Cuylaerts, Tania Crucitti, L Heyndrickx, et al.
Pagina's: 2038-2047 - MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency(2012)
Auteurs: K. Grupping, Philippe Selhorst, J Michiels, K Vereecken, L Heyndrickx, P. Kessler, Guido Vanham, L. Martin, Kevin Ariën
Pagina's: 1-16